Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Am J Prev Med. 2019 Oct;57(4):e135–e142. doi: 10.1016/j.amepre.2019.05.015

Impact of Brief Nicotine Messaging on Nicotine-Related Beliefs in a U.S. Sample

Andrea C Villanti 1, Julia C West 1, Darren Mays 2, Eric C Donny 3, Joseph N Cappella 4, Andrew A Strasser 5
PMCID: PMC6756180  NIHMSID: NIHMS1539015  PMID: 31542145

Abstract

Introduction:

The current study pilot tested the effect of a single, brief exposure to nicotine education messages on beliefs about nicotine, nicotine-replacement therapy (NRT), e-cigarettes, and cigarettes with reduced nicotine content (RNC).

Methods:

Five hundred twenty-one U.S. adults (aged ≥18 years) on Amazon Mechanical Turk completed a 15-minute survey in 2018. After completing items on sociodemographics, literacy, and cancer risk behaviors, participants were randomized in a 2:1:1 ratio to one of three conditions: nicotine education (n=263), sun safety education (attention control, n=128), or no message control (n=130). All participants completed items regarding nicotine, NRT, e-cigarette, and RNC cigarette beliefs, as well as norms about nicotine use, behavioral control regarding cigarette/tobacco use, and intention to use cigarettes, NRT, e-cigarettes, and RNC cigarettes in the next 12 months. Analyses were conducted in 2019.

Results:

Following exposure, nicotine education participants reported fewer false beliefs about nicotine (p<0.001), NRT (p<0.001), e-cigarettes (p<0.05), and RNC cigarettes (p<0.05) compared with the control conditions. Nicotine messaging doubled the probability of a correct response (false, 78.3% vs 36.8%) to nicotine is a cause of cancer and dramatically reduced the probability of responding don’t know to this item (5.3% vs 26.0%). There was no impact of the intervention on beliefs about other substances within cigarette, norms, or behavioral intentions.

Conclusions:

Findings from the current study support that a brief nicotine messaging intervention—similar to the messages likely to be seen on warning labels or in media campaigns—is likely to correct misperceptions of nicotine, NRT, e-cigarettes, and RNC cigarettes.

INTRODUCTION

Authoritative reviews of carcinogens in tobacco and tobacco smoke have not listed nicotine among the carcinogens14 and evidence syntheses conclude that combustion compounds in tobacco smoke are the primary contributors to the cardiovascular risk of tobacco use.5,6 However, population studies have quantified widespread misperceptions of nicotine,79 with some smokers equating the harms of using U.S. Food and Drug Administration-approved nicotine-replacement therapy (NRT) for smoking cessation with the harms of cigarette smoking.1016

Findings from RCTs support that cigarettes with reduced nicotine content (RNC) can reduce cigarettes per day, and exposure to and dependence on nicotine, with minimal smoking compensation among users.17,18 The Food and Drug Administration is considering a nicotine reduction standard in cigarettes, but has not described how consumer education on nicotine would be used to support the intended effect of this policy on current tobacco users, non-users, or the population overall.19

The goal of the current study was to pilot test the effect of a single, brief exposure to nicotine educational messages on beliefs about nicotine, NRT, e-cigarettes, and RNC cigarettes in a convenience sample of adults.

METHODS

Study Sample

The authors conducted an online trial in 521 U.S. adults (aged ≥18 years) on Amazon Mechanical Turk who completed a 15-minute survey on “Communicating About Cancer Risk Behaviors” in 2018. After completing items on sociodemographics, literacy,20 and cancer risk behaviors (e.g., physical activity), participants were randomized in a 2:1:1 ratio to one of three conditions: nicotine messaging (n=263), sun safety messaging (attention control, n=128), or no message control (n=130). Participants in the “no message control” condition immediately completed outcome measures. Participants in the two messaging intervention conditions completed these items after exposure to the educational messages. This study was deemed exempt by the IRB at the University of Vermont.

Intervention

Six images were presented to participants in the nicotine messaging condition using a black slide template with smoke and content adapted from several evidence-based sources 13,5,21,22 for a lay audience. The six tested messages were: (1) nicotine is the addictive substance in tobacco products, (2) nicotine makes it easier for people to start smoking regularly, (3) nicotine makes it harder for people to quit smoking, (4) nicotine does not cause cancer, (5) chemicals in cigarette smoke, not nicotine, largely cause cancer, heart disease, and other health problems related to smoking, and (6) nicotine can be used safely long-term in quit smoking products like nicotine patches, gum, or lozenges. Participants in the sun safety condition also received six messages of similar length to the nicotine messages using an orange slide template with a sun, including indoor tanning and ultraviolet radiation from the sun cause skin cancer and premature aging and wearing sunscreen alone does not prevent skin cancer.

Measures

Primary outcomes were nicotine, NRT, e-cigarette, and RNC cigarette beliefs. Secondary outcomes were norms about nicotine use, behavioral control regarding cigarette/tobacco use, and intention to use cigarettes, NRT, e-cigarettes, and RNC cigarettes in the next 12 months. These measures are detailed with their response options in Tables 2 and 3. Items on the relative harm of e-cigarettes or nicotine products compared with cigarettes were initially asked on a 5-point scale (much less harmful to much more harmful), but collapsed to a 3-point scale. Nine items on RNC cigarette beliefs were adapted from previous studies23,24 and assessed on a 5-point scale from definitely not true to definitely true. Items were summed to create subscales, with higher scale values indicating a greater number of false beliefs. Norms items on the social acceptability of specific tobacco products and other substances were assessed on a 5-point scale (not at all to extremely) and items on people’s opinions of using nicotine on a 5-point scale (very positive to very negative). Acceptability of uses of nicotine was assessed by ranking three options from most acceptable (1) to least acceptable (3). Intention to use specific products in the next 12 months was assessed in past 30–day tobacco users and non-users, with those reporting definitely yes, probably yes, and probably not coded as susceptible to future use and those reporting definitely not coded as not susceptible, in line with other studies.25,26

Table 2.

Differences in Nicotine and Cigarette Beliefs, by Study Condition

Study condition
Beliefs Nicotine messaging (n=263) Combined controls (n=258) p-value
Thinking about the harm that individual substances within a cigarette may cause, how much harm comes froma
 Substances produced when raw tobacco burns? (missing=25) 3.30 (1.31) 3.21 (1.26) 0.44
 The nicotine in a cigarette? (missing=23) 2.34 (1.36) 3.13 (1.29) <0.001
 Naturally occurring substances in tobacco? (missing=23) 2.66 (1.23) 2.70 (1.21) 0.69
 Things that are added to cigarettes during the manufacturing process? (missing=23) 3.94 (1.11) 3.91 (1.13) 0.79
Nicotine false beliefs
 Nicotine is a cause of cancerb <0.001
  False 78.3 36.8
  Don’t know 5.3 26.0
  True 16.4 37.2
 In your opinion, how large a part of the health risks of cigarette smoking comes from the nicotine itself?b <0.001
  None/small part 76.4 55.8
  Large/very large part 23.6 44.2
 In your opinion, how large a part of the cancer caused by cigarette smoking comes from the nicotine itself?b <0.001
  None/small part 84.0 62.8
  Large/very large part 16.0 37.2
 Nicotine false beliefs scale (α=0.86)a,c 4.90 (2.06) 6.71 (2.48) <0.001
NRT false beliefs
 It is easy to get addicted to nicotine gumb 0.321
  False 13.3 11.6
  Don’t know 26.2 32.2
  True 60.5 56.2
 Long term use of nicotine from patches or gums is almost as harmful to health as cigarette smokingb <0.001
  False 59.3 33.7
  Don’t know 21.3 24.4
  True 19.4 41.9
 Are nicotine products (like gum, patches, lozenges) more likely, about the same, or less likely to cause someone to become addicted as regular cigarettes?b 0.016
  Less likely 40.7 29.1
  About the same 47.9 55.0
  More likely 11.4 15.9
 Are nicotine products (like gum, patches, lozenges) more likely, about the same, or less likely to cause someone to have a heart attack as regular cigarettes?b(missing=1) <0.001
  Less likely 62.7 44.7
  About the same 27.8 44.4
  More likely 9.5 10.9
 Are nicotine products (like gum, patches, lozenges) more likely, about the same, or less likely to cause cancer as regular cigarettes?b 0.001
  Less likely 72.2 56.2
  About the same 22.1 32.9
  More likely 5.7 10.9
 Relative harm of nicotine products (like gum, patches, lozenges) compared to cigarettesb 0.010
  Less harmful 76.4 64.3
  About the same 16.0 24.0
  More harmful 7.6 11.6
 NRT false beliefs scale (α=0.74)a,d 9.89 (2.63) 11.07 (2.84) <0.001
E-cigarette false beliefs
 Long term use of electronic cigarettes (e-cigarettes) is almost as harmful to health as cigarette smokingb 0.022
  False 35.0 30.6
  Don’t know 27.8 20.5
  True 37.3 48.8
 Are electronic cigarettes (e-cigarettes) more likely, about the same, or less likely to cause someone to have a heart attack as regular cigarettes?b (missing=1) 0.059
  Less likely 52.9 42.8
  About the same 38.4 48.2
  More likely 8.7 8.9
 Are electronic cigarettes (e-cigarettes) more likely, about the same, or less likely to cause cancer as regular cigarettes?b (missing=1) 0.038
  Less likely 57.0 47.1
  About the same 34.2 45.1
  More likely 8.7 7.8
 Relative harm of e-cigarettes (like JUUL, Vuse, MarkTen, blu, or Joyetech) compared to cigarettesb (missing=2) 0.463
  Less harmful 61.3 56.6
  About the same 28.4 33.3
  More harmful 10.3 10.1
 E-cigarette false beliefs scale (α=0.79)a,e 6.58 (2.21) 6.97 (2.24) 0.043
Reduced nicotine content cigarette false beliefs
 Cigarettes that are lower in nicotine are less likely to cause cancer than regular cigarettesa 2.05 (1.07) 2.29 (1.01) 0.010
 Cigarettes that are lower in nicotine are safer than regular cigarettesa 2.16 (1.11) 2.32 (1.09) 0.110
 Cigarettes that are lower in nicotine are healthier than regular cigarettesa 2.10 (1.09) 2.24 (1.14) 0.137
 Cigarettes that are lower in nicotine have fewer chemicals than regular cigarettesa 2.14 (1.11) 2.24 (1.12) 0.289
 Smoking cigarettes that are lower in nicotine make it easier to quit smoking completely compared to regular cigarettesa,f 2.81 (1.13) 3.03 (1.10) 0.024
 Cigarettes that are lower in nicotine also have less tar than regular cigarettesa 2.40 (1.03) 2.38 (1.03) 0.810
 High nicotine content cigarettes are worse for your health than low nicotine cigarettes, even if you smoke the same number of eacha 2.63 (1.16) 2.82 (1.13) 0.053
 A low nicotine cigarette is safer to smoke than a high nicotine cigarette, even if you don’t quita 2.35 (1.14) 2.41 (1.08) 0.545
 Low nicotine cigarettes are healthier for you than high nicotine cigarettes even before you quita 2.53 (1.16) 2.44 (1.09) 0.372
 RNC cigarette false beliefs scale (α=0.91)a,g 20.99 (6.80) 22.16 (6.53) 0.047

Notes: If missing number not provided, there is not missing data on that item. Boldface indicates statistical significance (p<0.05).

a

Mean (SD).

b

Column percent.

c

Nicotine false beliefs scale comprised of 3 items (listed above in this table; range 3–11).

d

NRT false beliefs scale comprised of 6 items (listed above in this table; range 6–18).

e

E-cigarette false beliefs scale comprised of 4 items (listed above in this table; range 3–12).

f

This item was reverse-coded.

g

RNC cigarette false beliefs scale comprised of 9 items (listed above in this table; range 9–39).

NRT, nicotine replacement therapy; RNC, reduced nicotine content.

Table 3.

Norms, Behavioral Control, and Intention to Use Nicotine and Tobacco, by Study Condition

Variable Nicotine messaging Combined controls p-value
Norms, full sample (n=263) (n=258)
 How socially acceptable among your peers do you think each of the following products are?a
  Nicotine 2.45 (1.10) 2.60 (1.14) 0.132
  Caffeine 4.53 (0.79) 4.51 (0.86) 0.776
  Alcohol 3.94 (0.97) 4.02 (1.04) 0.410
  Marijuana 3.04 (1.23) 3.25 (1.19) 0.049
  Cigarettes 2.48 (1.16) 2.47 (1.22) 0.924
  E-cigarettes 2.80 (1.17) 3.00 (1.26) 0.059
  Nicotine products (i.e., gum, patches, lozenges) 2.89 (1.23) 2.83 (1.30) 0.635
  Hookah 2.63 (1.23) 2.77 (1.26) 0.187
  Low nicotine cigarettes 2.33 (1.14) 2.42 (1.14) 0.400
 Rank the following three uses of nicotine in terms of their acceptability to you and people like youa (range: 1–3)
  Nicotine delivered via the patch for cessation of tobacco use (missing=78) 1.76 (0.86) 1.90 (0.86) 0.086
  Nicotine delivered via the e-cigarettes for either cessation or harm reduction (missing=78) 1.89 (0.67) 1.85 (0.69) 0.533
  Nicotine delivered via e-cigarettes for purposes other than cessation or harm reduction (i.e., recreational use of e-cigarettes) (missing=78) 2.35 (0.80) 2.25 (0.84) 0.196
 Opinion of using nicotinea
  Most people 3.78 (0.90) 3.79 (0.86) 0.845
  People who are important to you 3.74 (1.01) 3.80 (0.96) 0.483
Behavioral control among past 30-day tobacco users (n=97) (n=109)
 How confident are you that you could resist smoking a cigarette in situations where others are smoking?b 0.722
  Not at all confident 23.7 23.9
  Somewhat confident 33.0 36.7
  Moderately confident 21.7 15.6
  Very confident 21.6 23.9
 How confident are you that you can quit smoking cigarettes/using tobacco products totally and for good if and when you wanted to?b 0.789
  Not at all confident 19.6 19.3
  Somewhat confident 42.3 41.3
  Moderately confident 17.5 13.8
  Very confident 20.6 25.7
 If a tobacco product made a claim that it was less harmful to health than other tobacco products, how likely would you be to use that product?b 0.439
  Very likely 16.5 10.1
  Somewhat likely 32.0 34.9
  Somewhat unlikely 24.7 25.7
  Very unlikely 16.5 22.9
  Don’t know 10.3 6.4
Intention to use among past 30-day tobacco users (n=97) (n=109)
 Cigarettesb 0.768
  No 12.4 13.8
  Yes 87.6 86.2
 E-cigarettesb 0.539
  No 9.3 11.9
  Yes 90.7 88.1
 Low nicotine cigarettesb 0.597
  No 21.7 24.8
  Yes 78.3 75.2
 NRTb 0.441
  No 23.7 28.4
  Yes 76.3 71.6
Intention to use among non-past 30-day tobacco users (n=166) (n=149)
 Cigarettesb 0.378
  No 85.5 81.9
  Yes 14.5 18.1
 E-cigarettesb 0.143
  No 80.1 73.2
  Yes 19.9 26.8
 Low nicotine cigarettesb 0.382
  No 88.6 85.2
  Yes 11.4 14.8
 NRTb 0.912
  No 91.0 90.6
  Yes 9.0 9.4

Notes: If missing number not provided, there is not missing data on that item. Boldface indicates statistical significance (p<0.05).

a

Mean (SD).

b

Column percent.

NRT, nicotine replacement therapy.

Statistical Analysis

Bivariate analyses examined differences in sociodemographic characteristics (age, gender, race/ethnicity, education, subjective financial situation), past 30–day tobacco use, and response to nicotine, NRT, e-cigarette, and RNC cigarette beliefs, norms, behavioral control, and intention to use by study condition using chi-square tests and t-tests in 2019. As there were no significant differences in the primary outcomes between the two control conditions, comparisons focused on the nicotine messaging versus combined control conditions. Multiple linear regression analyses examined the relationship between study condition and the four false beliefs scales, controlling for past 30–day tobacco use status.

RESULTS

Approximately half of participants were male (52%), 46% were aged 25–34 years, 80% were white, 11% were of Hispanic ethnicity, 87% had at least some college education, and 40% reported past 30–day tobacco or e-cigarette use (Table 1). The study groups did not differ on pre-exposure measures of sociodemographic characteristics, literacy, or past 30–day tobacco use.

Table 1.

Participant Characteristics and Baseline Smoking Beliefs, by Study Condition

Study condition
Characteristics Nicotine messaging (n=263) % Combined controls (n=258) % Total

(n=521) %
p-value
Sex 0.516
 Female 46.8 49.6 48.2
 Male 53.2 50.4 51.8
Age, years 0.605
 18–24 9.5 11.6 10.6
 25–34 44.9 46.9 45.9
 35–44 27.4 20.9 24.2
 45–54 8.4 10.5 9.4
 55–64 6.8 7.4 7.1
 ≥65 3.0 2.7 2.9
Hispanic ethnicity 0.524
 No 88.6 90.3 89.4
 Yes 11.4 9.7 10.6
Race 0.342
 White 82.1 79.1 80.6
 Black or African American 8.4 6.6 7.5
 American Indian or Alaska Native 1.1 0.8 1.0
 Asian 5.3 8.5 6.9
 More than 1 race 2.7 3.1 2.9
 Other 0.4 1.9 1.2
Highest level of education completed 0.282
 Less than high school 0.4 1.6 1.0
 High school/GED 14.1 10.9 12.5
 Some college/Associate’s degree 35.7 32.9 34.4
 Bachelor’s/Advanced degree 49.8 54.7 52.2
Subjective financial status 0.949
 Live comfortably 22.1 23.3 22.6
 Meet needs with a little left 43.7 44.2 44.0
 Just meet basic expenses 30.4 28.3 29.4
 Don’t meet basic expenses 3.8 4.3 4.0
Single-item literacy screener 0.468
 Adequate reading ability 87.5 85.3 86.4
 Limited reading ability 12.5 14.7 13.6
Use of tobacco products, past 30 days 0.434
 None 63.1 57.8 60.5
 Other tobacco products only 5.7 6.2 6.0
 E-cigarettes 6.1 10.1 8.1
 Cigarettes 18.6 17.8 18.2
 Cigarettes and e-cigarettes 6.5 8.1 7.3
Baseline smoking beliefsa
 Nicotine is the main substance in tobacco that makes people want to smoke 1.95 (1.03) 2.08 (1.13) 2.01 (1.08) 0.179
 Smoking behavior is something basic about a person that they can’t change very much 4.89 (1.26) 4.91 (1.32) 4.90 (1.29) 0.851

Notes: Missing data: None. Column percentages unless otherwise noted. Boldface indicates statistical significance (p<0.05).

a

Mean (SD).

Table 2 shows a strong effect of nicotine messaging on reducing false beliefs about nicotine, NRT, e-cigarettes, and RNC cigarettes compared with the combined control conditions. Importantly, the nicotine messaging condition doubled the probability of a correct response (false, 78.3% vs 36.8%) to nicotine is a cause of cancer and dramatically reduced the probability of responding don’t know to this item (5.3% vs 26.0%). It also increased correct responses regarding the contribution of nicotine to health risks and cancer caused by cigarette smoking (p<0.001). Of particular interest, the impact of the educational intervention was specific to nicotine; there was no impact on beliefs about other substances within a cigarette (p>0.040 for all). In multivariable models, exposure to nicotine messaging remained associated with a lower level of nicotine (b= −1.82, p<0.001), NRT (b= −1.16, p<0.001), and e-cigarette (b= −0.39, p=0.043) false beliefs, after controlling for past 30–day tobacco use; the relationship between study condition and RNC cigarette false beliefs in this model was marginally significant (b= −1.13, p=0.054).

There were no differences in nicotine-related norms, behavioral control, or intentions to use tobacco or nicotine products by study condition (Table 3). The only marginally significant difference between groups was for social acceptability of marijuana (p=0.049).

DISCUSSION

Findings from the current study support that a brief nicotine messaging intervention—similar to the messages likely to be seen on warning labels or in media campaigns—can correct misperceptions of nicotine, NRT, e-cigarettes, and RNC cigarettes in a general population sample of adults. Brief exposure to nicotine messages in this pilot study, however, did not impact norms about nicotine, behavioral control, or intention to use tobacco or nicotine products.

Limitations

This study used an online convenience sample and a single, brief exposure to sample nicotine education messages. While it provides encouraging preliminary evidence of the potential for messaging to correct misperceptions of nicotine, studies with repeated exposures in a population sample are needed to determine whether public education on nicotine would produce similar results in U.S. adults.

CONCLUSIONS

Public education is an essential complement to the Food and Drug Administration’s efforts to move smokers away from combusted tobacco products and prevent non-users from trying nicotine and tobacco products. Communication via mass media, warnings, and effective labeling are central components of such educational efforts, and must convey correct information in a way that the public understands. Studies with more intensive exposure to such messages are needed to determine the durability of these effects and extension to behavioral outcomes, as well as studies to examine their effects in subgroups of interest (e.g., tobacco users).

ACKNOWLEDGMENTS

The authors wish to thank Richard O’Connor for his contributions to study measures. The authors were supported by NIH under Awards R03CA212694 and P20GM103644 (ACV, JCW), U54DA036114 (ACV), U54DA031659 (ECD, AAS), and U54CA229973 (DM, ECD, JNC, AAS). The content is solely the responsibility of the authors and does not necessarily represent the official views of NIH.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

No financial disclosures were reported by the authors of this paper.

REFERENCES

  • 1.IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Smokeless Tobacco and Some Tobacco-specific N-Nitrosamines. WHO, International Agency for Research on Cancer; 2007. [PMC free article] [PubMed] [Google Scholar]
  • 2.IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Tobacco Smoking. WHO, International Agency for Research on Cancer; 2012. [Google Scholar]
  • 3.IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Smokeless Tobacco. WHO, International Agency for Research on Cancer; 2012. [Google Scholar]
  • 4.HHS. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta, GA: U.S. HHS, CDC, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2010. [PubMed] [Google Scholar]
  • 5.HHS. The Health Consequences of Smoking—50 Years of Progress A Report of the Surgeon General. Atlanta, GA: HHS, CDC, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014. [Google Scholar]
  • 6.Benowitz NL, Burbank AD. Cardiovascular toxicity of nicotine: implications for electronic cigarette use. Trends Cardiovasc Med 2016;26(6):515–523. 10.1016/j.tcm.2016.03.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.O’Brien EK, Nguyen AB, Persoskie A, Hoffman AC. U.S. adults’ addiction and harm beliefs about nicotine and low nicotine cigarettes. Prev Med 2017;96:94–100. 10.1016/j.ypmed.2016.12.048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Byron MJ, Jeong M, Abrams DB, Brewer NT. Public misperception that very low nicotine cigarettes are less carcinogenic. Tob Control. 2018;27(6):712–714. 10.1136/tobaccocontrol-2017-054124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Villanti A, West J, Pearson J, et al. Nicotine Beliefs in U.S. Young Adults, 2016. In: 2018 SRNT 24th Annual Meeting Baltimore, MD; 2018. [Google Scholar]
  • 10.Ferguson SG, Gitchell JG, Shiffman S, Sembower MA, Rohay JM, Allen J. Providing accurate safety information may increase a smoker’s willingness to use nicotine replacement therapy as part of a quit attempt. Addict Behav 2011;36(7):713–716. 10.1016/j.addbeh.2011.02.002. [DOI] [PubMed] [Google Scholar]
  • 11.Etter JF, Perneger TV. Attitudes toward nicotine replacement therapy in smokers and ex-smokers in the general public. Clin Pharmacol Ther 2001. ;69(3): 175–183. 10.1067/mcp.2001.113722. [DOI] [PubMed] [Google Scholar]
  • 12.Borrelli B, Novak SP. Nurses’ knowledge about the risk of light cigarettes and other tobacco “harm reduction” strategies. Nicotine Tob Res 2007;9(6):653–661. 10.1080/14622200701365202. [DOI] [PubMed] [Google Scholar]
  • 13.Bansal MA, Cummings KM, Hyland A, Giovino GA. Stop-smoking medications: who uses them, who misuses them, and who is misinformed about them? Nicotine Tob Res 2004;6(suppl 3):S303–S310. 10.1080/14622200412331320707. [DOI] [PubMed] [Google Scholar]
  • 14.Cummings KM, Hyland A, Giovino GA, Hastrup JL, Bauer JE, Bansal MA. Are smokers adequately informed about the health risks of smoking and medicinal nicotine? Nicotine Tob Res 2004;6(suppl 3):S333–S340. 10.1080/14622200412331320734. [DOI] [PubMed] [Google Scholar]
  • 15.Wikmans T, Ramstrom L. Harm perception among Swedish daily smokers regarding nicotine, NRT-products and Swedish Snus. Tob Induc Dis 2010;8:9 10.1186/1617-9625-8-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Shiffman S, Ferguson SG, Rohay J, Gitchell JG. Perceived safety and efficacy of nicotine replacement therapies among U.S. smokers and ex-smokers: relationship with use and compliance. Addiction. 2008;103(8):1371–1378. 10.1111/j.1360-0443.2008.02268.x. [DOI] [PubMed] [Google Scholar]
  • 17.Donny EC, Denlinger RL, Tidey JW, et al. Randomized trial of reduced-nicotine standards for cigarettes. N Engl J Med 2015;373(14):1340–1349. 10.1056/NEJMsa1502403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Higgins ST, Heil SH, Sigmon SC, et al. Addiction potential of cigarettes with reduced nicotine content in populations with psychiatric disorders and other vulnerabilities to tobacco addiction. JAMA Psychiatiy. 2017;74(10): 1056–1064. 10.1001/jamapsychiatry.2017.2355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.H.R 1256--111th Congress: Family Smoking Prevention and Tobacco Control Act GovTrack.us (database of federal legislation); 2009. [Google Scholar]
  • 20.Morris NS, MacLean CD, Chew LD, Littenberg B. The Single Item Literacy Screener: evaluation of a brief instrument to identify limited reading ability. BMC Fam Pract 2006;7:21 10.1186/1471-2296-7-21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.U.S. Food and Drug Administration. FDA’s Plan for Tobacco and Nicotine Regulation. www.fda.gov/TobaccoProducts/NewsEvents/ucm568425.htm Published 2017. Accessed February 7, 2018.
  • 22.U.S. Food and Drug Administration. Modifications To Labeling of Nicotine Replacement Therapy Products for Over-the-Counter Human Use. www.federalregister.gov/documents/2013/04/02/2013-07528/modifications-to-labeling-of-nicotine-replacement-therapy-products-for-over-the-counter-human-use Published 2013. Accessed July 3, 2018.
  • 23.Mercincavage M, Saddleson ML, Gup E, Halstead A, Mays D, Strasser AA. Reduced nicotine content cigarette advertising: how false beliefs and subjective ratings affect smoking behavior. Dmg Alcohol Depend 2017;173:99–106. 10.1016/j.drugalcdep.2016.12.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Strasser AA, Tang KZ, Tuller MD, Cappella JN. PREP advertisement features affect smokers’ beliefs regarding potential harm. Tob Control. 2008;17(suppl 1):i32–i38. 10.1136/tc.2007.022426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Pierce JP, Choi WS, Gilpin EA, Farkas AJ, Merritt RK. Validation of susceptibility as a predictor of which adolescents take up smoking in the United States. Health Psychol 1996; 15(5):355–361. 10.1037//0278-6133.15.5.355. [DOI] [PubMed] [Google Scholar]
  • 26.Pierce JP, Farkas AJ, Evans N, Gilpin E. An improved surveillance measure for adolescent smoking? Tob Control. 1995;4(suppl 1):S47–S56. 10.1136/tc.4.suppl1.s47. [DOI] [Google Scholar]

RESOURCES